Ebola vaccine troubles; scientists question brain-training; conversation with a stem cell pioneer
ISTOCK, MARK GILLOW
On his blog, the University of California, Davis’s Paul Knoepfler spoke about the clinical use of induced pluripotent stem cells with field pioneer and Nobel Laureate Shinya Yamanaka. “Stem cells provide unprecedented opportunities in stem cell therapy and drug development,” Yamanaka told Knoepfler. (Read about stem cell therapies for blindness in this month’s BioBusiness story, “Eyes on the Prize.”)
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and spot the effects of excipients on protein stability.
A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
In this webinar, learn how scientists are using cutting-edge spatial proteomics technologies to advance their understanding of cellular organization in healthy and diseased tissues.
Scientists rely on cytokines, growth factors, and other agents to direct and create different types of organoid models.
System strengthens Taiwan’s capabilities in protein drug discovery research
The Transferpette® pro expands the Transferpette® family, offering scientists even greater flexibility to match their pipetting preferences and workflow requirements.
Fast, gentle, and highly specific glycoprotein labeling compatible with downstream immunofluorescence, enabled by next-generation aminooxy chemistry.
Thermo Scientific X and S Series General Purpose Centrifuges are designed to help provide exceptional performance, versatility and enhanced sustainability.
